# Touch and manual action in chemotherapy-induced peripheral neuropathy: a mixed-methods study

**Authors:** Roberta D. Roberts, Winnie Chua, Ali Khatibi, Nicholas P. Holmes, Claire Palles, Racha Kussaibati, Alan M. Wing

PMC · DOI: 10.1038/s41598-026-46039-2 · Scientific Reports · 2026-03-29

## TL;DR

This study explores how chemotherapy-induced peripheral neuropathy affects touch and manual tasks like gripping and handling objects, based on patient experiences.

## Contribution

The study introduces a mixed-methods approach to understand how CIPN impacts manual activities, combining patient reports with theoretical hypotheses.

## Key findings

- Participants reported varying impacts of touch impairments on bimanual, unimanual, and directed touch tasks.
- Altered touch experiences led to hypotheses about why certain manual tasks are more affected by CIPN.
- Future research should combine patient-reported outcomes with quantitative measures to better understand sensory-motor control issues.

## Abstract

Chemotherapy induced peripheral neuropathy (CIPN) is a frequent side effect of a number of chemotherapeutic agents which are widely used in the treatment of common cancers. Sensory symptoms primarily affect the fingers and toes and include numbness, tingling and pain. However, there is limited understanding of how these touch impairments may impact manipulation skills. Questionnaire and focus group methods were used to describe the experience of CIPN side effects impacting manual activities in 25 self-selected participants recruited from a cancer charity web site advertisement. Participants’ responses demonstrated varying degrees of impact of touch impairment associated with CIPN on the performance of manual activities involving bimanual, unimanual and directed touch. Examination of the components of the affected activities, together with participants’ reports of alterations in their experience of touch, were used to generate theory-informed hypotheses about why some manual tasks are more affected than others. In future research it is proposed that quantitative objective measures should be used to complement patient reported outcome measures in evaluating the mechanisms underlying issues in sensory motor control of manual activities caused by the effects of CIPN.

The online version contains supplementary material available at 10.1038/s41598-026-46039-2.

## Full-text entities

- **Diseases:** tingling (MESH:D010292), stocking and glove syndrome (MESH:D013577), blind (MESH:D001766), loss of tactile sensation (MESH:D006212), Neurotoxicity (MESH:D020258), Cancer (MESH:D009369), Impaired dexterity (MESH:D060825), impaired touch (MESH:D020886), cramp (MESH:D009120), CIPN impairment (MESH:D000084202), burns (MESH:D002056), loss of sensation (MESH:D006987), Pain (MESH:D010146), Deficits (MESH:D009461), muscle weakness (MESH:D018908), Dry skin (MESH:D015352), sensory impairment (MESH:D012678), CIPN (MESH:D010523), breast, prostate, lung and gastrointestinal malignancies (MESH:D001943), allodynia (MESH:D006930), incoordination (MESH:D001259)
- **Chemicals:** PNQ (-), Lenvatinib (MESH:C531958), Pertuzumab (MESH:C485206), Cyclophosphamide (MESH:D003520), taxanes (MESH:D043823), Bortezomib (MESH:D000069286), platinum (MESH:D010984)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039469/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13039469/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC13039469/full.md

---
Source: https://tomesphere.com/paper/PMC13039469